Handbook to assess foodborne disease burden: WHO shows the way
The handbook aims to develop framework for routine updating estimates; provide baseline against which food safety interventions can be evaluated
Why India should prepare for COVID-19 recovered patients as ‘next big health crisis’
A recent study says besides other long-term health risks, patients face higher chance of death even after six months of recovery
Measles campaigns suspended in most countries; 140 million lives at stake, mostly children
In many countries the regular measles vaccine campaigns are delayed by over a year due to the pandemic disruptions
Coronavirus: Enough drug ingredients, says govt, refuses to go into detail
Union Health minister says India will not repatriate citizens stuck on ship in Japan
Experts raise questions on FSSAI draft about conflict of interest
The draft is silent on many aspects which proves that FSSAI wants to remain non-transparent, they say
Dementia going to increase three-fold by 2050
The estimated annual global cost of dementia is US$ 818 billion, equivalent to more than 1 per cent of global GDP
Indian government is not doing enough to tackle the sale of unapproved antibiotics
India's laissez-faire attitude to drug regulation is a serious threat to global efforts
Resistance in gonorrhoea-causing bacteria is increasing and there are no new drugs
The World Health Organization has cautioned against the building resistance and emphasised on the need for new drugs
World Malaria Day: sub-Saharan Africa in the spotlight
WHO recommends a package of prevention approaches, including insecticide-treated nets, spraying indoor walls with insecticides and preventive …
Depression, an invisible burden for TB patients; and we must urgently address this
The risk of people with mental disorders being prone to developing TB has often been overlooked
New treatment against drug-resistant TB successful
Multidrug-resistant TB is a serious public health challenge. It affects vulnerable communities such as migrant workers, refugees, prisoners and …
WHO’s new programme to eliminate neglected tropical diseases in Africa
These diseases affect economically poorer sections having severe impact on their lives and progress
WHO issues guidelines to prevent child and maternal deaths
Every year, 2.6 million children are stillborn and 303,000 births result in mother’s death
Trump starts withdrawing US from WHO
Withdrawal process to take at least a year, will be effective from July 6, 2021
Impact of environment on health: Africa adopts strategy for better synergy between sectors
New strategy also integrates recommendations for healthy recovery from COVID-19 pandemic
World Cancer Day: Southeast Asia should strengthen diagnosis, treatment, palliative care tools
Cervical cancer is the second-most prevalent in southeast Asia
The missing piece in Omicron’s family tree: Where did the variant originate?
There are currently 3 thoeries being considereed by the medical fraternity
World Health Day: Indian tale of unfulfilled goals
India short of five lakh doctors and the situation is worse than Vietnam
WHO has ended the COVID-19 global health emergency — what happens now?
The ‘end of the pandemic’ might have several ramifications
Why declaring Ebola a public health emergency isn't a silver bullet
More funding can't solve the outbreak of a deadly disease within a conflict zone
High-efficacy malaria vaccine manufactured by Serum Institute passes WHO quality checks
R21/Matrix-M malaria vaccine added to the WHO's list of prequalified vaccines
43% increase in measles deaths from 2021-2022: WHO
Number of cases rose by 18% in a year; 15 more countries reported measles outbreaks in 2022
India, Indonesia and the Philippines account for over 60% drop in tuberculosis reporting in 2020 and 2021
WHO report finds TB still world’s second leading cause of death from a single infectious agent
In-depth: What ails India’s coronavirus genome sequencing system
The country sequenced only 0.2% samples till date, one of the lowest in the world
WHO approves Tocilizumab for COVID-19 treatment
Extremely high price, poor availability bottlenecks in drug usage